FDA concerned Iterum’s urinary tract infection drug could cause antimicrobial resistance
Edwards cuts more than 500 employees after critical care sale
Bristol-Myers Squibb-backed Zenas BioPharma seeks up to $689.7 mln valuation in US IPO
What 3 layoff stories reveal about pharma’s troubles
*please scroll down for all the latest news*
